Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access April 17, 2010

Effects of intra-arterial heparin on cytokine levels in the ischemic tissue

Sami Karapolat and Bilgehan Erkut
From the journal Open Medicine

Abstract

The purpose of this study was to evaluate the effects of systemic and intra-arterial application of heparin by measuring tissue levels of inflammatory cytokines. Twenty-one adult male Wistar albino rats were divided into three groups (Group A, B and C). All the rats had undergone ligation of the right femoral artery with 4-0 silk suture to induce limb ischemia. Group A was the control group. In Group B, unfractionated heparin of 1500 U/kg/day was given through the tail vein for 10 days, the same dose was given to distal part of ligated right femoral artery for 10 days in Group C. On the 3rd, 5th, and 10th days, biopsies were taken from rectus femoris muscle on the ischemic extremities. Tumor necrosis factor-α, interleukin-1β, and vascular cell adhesion molecule levels in muscle tissue were measured by a standard enzyme-linked immunoabsorbent assay method. An increase in tumor necrosis factor-α level was found in all three groups throughout the duration of the experiment. The increase in Group C was statistically significant as compared with the other groups. The significant increases that occurred in tumor necrosis factor-α level as a result of intra-arterial application of heparin can be postulated to be one of the results of angiogenesis induced by the heparin in ischemic extremities. This might delay the formation of a necrosis in ischemic extremities, depending on the increased angiogenesis response by means of intra-arterial heparin application and may result in extended vitality of an extremity.

[1] Karapolat S, Dag O, Abanoz M, Aslan M. Arterial embolectomy, a retrospective evaluation of 730 cases over 20 years. Surg Today. 2006,36, 416–419 http://dx.doi.org/10.1007/s00595-005-3156-710.1007/s00595-005-3156-7Search in Google Scholar PubMed

[2] Sugano M, Tsuchida K, Hata T, Makino N. In vivo transfer of soluble TNF-α receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats. Faseb J. 2004,18, 911–913 10.1096/fj.03-1148fjeSearch in Google Scholar PubMed

[3] Shteinberg D, Halak M, Shapiro S, Kinarty A, Sobol E, Lahat N, et al. Abdominal aortic aneurysm and aortic occlusive disease, a comparison of risk factors and inflammatory response. Eur J Vasc Endovasc Surg. 2000,20, 462–465 http://dx.doi.org/10.1053/ejvs.2000.121010.1053/ejvs.2000.1210Search in Google Scholar PubMed

[4] Mousa SA. Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation, emerging links. Semin Thromb Hemost. 2007,33, 524–533 http://dx.doi.org/10.1055/s-2007-98208410.1055/s-2007-982084Search in Google Scholar PubMed

[5] Khorana AA, Sahni A, Altland OD, Francis CW. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight. Arterioscler Thromb Vasc Biol. 2003;23: 2110–2115 http://dx.doi.org/10.1161/01.ATV.0000090671.56682.D710.1161/01.ATV.0000090671.56682.D7Search in Google Scholar PubMed

[6] Singh S, Padmanabhan R, Singh G, Kaur G. Effect of maternal hypervitaminosis A during late gestation on pre- & postnatal lung maturation in rat. Indian J Exp Biol. 1983, 3, 103–107 Search in Google Scholar

[7] Schreyer SA, Peschon JJ, LeBoeuf RC. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem. 1996,271, 26174–26178 http://dx.doi.org/10.1074/jbc.271.42.2617410.1074/jbc.271.42.26174Search in Google Scholar PubMed

[8] Sugano M, Tsuchida K, Makino N. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia. Circulation 2004,109, 797–802 http://dx.doi.org/10.1161/01.CIR.0000112579.61522.6710.1161/01.CIR.0000112579.61522.67Search in Google Scholar PubMed

[9] Collen A, Smorenburg SM, Peters E, Lupu F, Koolwijk P, Van Noorden C, et al. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res. 2000,60, 6196–6200 Search in Google Scholar

[10] Guo DQ, Wu LW, Dunbar JD, Ozes ON, Mayo LD, Kessler KM, et al. Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factorinduced endothelial cell proliferation. J Biol Chem. 2000,275, 11216–11221 http://dx.doi.org/10.1074/jbc.275.15.1121610.1074/jbc.275.15.11216Search in Google Scholar PubMed

[11] Roesel JF, Nanney LB. Assessment of differential cytokine effects on angiogenesis using an in vivo model of cutaneous wound repair. J Surg Res. 1995,58, 449–459 http://dx.doi.org/10.1006/jsre.1995.107110.1006/jsre.1995.1071Search in Google Scholar PubMed

[12] Cervera A, Justicia C, Reverter JC, Planas AM, Chamorro A. Steady plasma concentration of unfractionated heparin reduces infarct volume and prevents inflammatory damage after transient focal cerebral ischemia in the rat. J Neurosci Res. 2004,77, 565–572 http://dx.doi.org/10.1002/jnr.2018610.1002/jnr.20186Search in Google Scholar PubMed

[13] Carroll SM, White FC, Roth DM, Bloor CM. Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion. Circulation 1993,88, 198–207 10.1161/01.CIR.88.1.198Search in Google Scholar

[14] Chamorro A, Cervera A, Castillo J, Davalos A, Aponte JJ, Planas AM. Unfractionated heparin is associated with a lower rise of serum vascular cell adhesion molecule-1 in acute ischemic stroke patients. Neurosci Lett. 2002,328, 229–232 http://dx.doi.org/10.1016/S0304-3940(02)00518-910.1016/S0304-3940(02)00518-9Search in Google Scholar

[15] O’Blenes SB, Merklinger SL, Jegatheeswaran A, Campbell A, Rabinovitch M, Rebeyka I, et al. Low molecular weight heparin and unfractionated heparin are both effective at accelerating pulmonary vascular maturation in neonatal rabbits. Circulation 2003,108, 161–166 http://dx.doi.org/10.1161/01.CIR.0000080289.72166.CF10.1161/01.CIR.0000080289.72166.CFSearch in Google Scholar PubMed

Published Online: 2010-4-17
Published in Print: 2010-4-1

© 2009 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Scroll Up Arrow